Lannett Company Inc. recalls Niacin Extended-release Tablets
- Published
- 10 Jun 2026
- Units affected
- 3984 bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
- Brand / company
- Lannett Company Inc.
- Codes / lots
- Lot #: 25282724A, Exp. Date 2027/01
- Distribution
- Nationwide within the United States
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 10 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.